| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Mereo BioPharma Group plc | General Counsel | American Depositary Shares representing Ordinary Shares | 219K | $925K | $4.22 | 13 Sep 2024 | Direct |
| Mereo BioPharma Group plc | General Counsel | Share Options (Right to buy) | 262K | $265K | $1.01 | 25 Jan 2025 | Direct |
| Mereo BioPharma Group plc | General Counsel | Performance Based Restricted Stock Unit | 0 | 11 Sep 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MREO | Mereo BioPharma Group plc | 25 Jan 2025 | 1 | $0 | 4 | General Counsel | 28 Jan 2025, 16:05 |
| MREO | Mereo BioPharma Group plc | 12 Sep 2024 | 2 | -$133K | 4 | General Counsel | 16 Sep 2024, 20:48 |
| MREO | Mereo BioPharma Group plc | 11 Sep 2024 | 2 | $0 | 4 | General Counsel | 13 Sep 2024, 16:57 |
| MREO | Mereo BioPharma Group plc | 25 Jun 2024 | 2 | -$162K | 4 | General Counsel | 27 Jun 2024, 16:15 |
| MREO | Mereo BioPharma Group plc | 21 Jun 2024 | 2 | $0 | 4 | General Counsel | 25 Jun 2024, 18:14 |
| MREO | Mereo BioPharma Group plc | 25 Jan 2024 | 1 | $0 | 4 | General Counsel | 26 Jan 2024, 16:15 |
| MREO | Mereo Biopharma Group plc | 01 Jan 2024 | 0 | $0 | 3 | General Counsel | 02 Jan 2024, 16:18 |